
Coinlist Announces Covalent Token Sale Starting April 29
The Covalent token as the native token for the Covalent network will be used as a governance token.
The Bowhead platform comprises of the Bowhead hardware device which monitors a customer's biometric data to dispense personalized medicine and...
The Bowhead platform comprises of the Bowhead hardware device which monitors a customer’s biometric data to dispense personalized medicine and supplements. Their “Anonymized Healthcare Token” allows customers and Bowhead token holders to receive compensation for the leasing of medical data which patients have full control of via smart contracts.
To be announced
To be announced
Mon, Jul 17th, 2017 12:00 AM
Thu, Aug 31st, 2017 12:00 AM
Canada
AHT
Waves
ERC20
Dr. Rhea Mehta - CEO
Dr. Francisco Diaz-Mitoma - Chairman
Saúl Ibaven Bueno - CTO
Francisco Diaz-Mitoma Jr - Head of Product
Cristina Randall - Co-Founder of Conekta
Raja Jindal - Co-Founder of Santa Barbara-based BIOIQ
Peter Kroll - Inventor of the Bitcoin Paper Wallet
Dr. Young-in Kim - Gastroenterologist in the Division of Gastroenterology at St. Michael’s Hospital
Disclosure: This page is created to provide market intelligence. This is not investment advice and does not constitute any solicitation or endorsement of any investment. Any investment you make is done at your own risk and at your full and absolute discretion.
The Covalent token as the native token for the Covalent network will be used as a governance token.
According to Bittrex, the exchange will accept payments in US dollars (USD), Tether (USDT), or Bitcoin (BTC). Trading will be available round-the-clock seven days a week.
The success of the public sale will permit INVIZION to kickstart its initiative which combines blockchain technology, DeFi (Decentralized Finance) and IoT (Internet of Things) solutions.